Fetal Stem Cell Extracellular Vesicles for Innate Immunity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current vaccines and antibody therapies primarily activate the adaptive immune system to prevent or treat infectious diseases, neglecting the innate immune system, which deteriorates after birth and lacks effective activation methods.

Innovation Solution

Development of fetal stem cell-derived extracellular vesicles containing immunoglobulins such as IgG3, IgM, IgA, IgD, and IgE, produced under culture conditions mimicking pregnancy, to enhance innate immunity by promoting the secretion and expression of natural antibodies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current vaccines and antibody therapies are used to prevent or treat infectious diseases, then the adaptive immune system is activated, but the innate immune system deteriorates after birth and lacks effective activation methods

Engineering Contradiction:
Improveeffectiveness of immune responseVSAvoidactivation capability of innate immune system
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent uses fetal stem cell-derived extracellular vesicles as an intermediary carrier to deliver natural antibodies (IgM, IgG3, IgA, IgD, IgE) to the host system. These vesicles act as a bridge between the innate and adaptive immune systems, enabling activation of innate immunity without direct vaccination approaches. The vesicles protect the immunoglobulins during delivery and facilitate their integration into the host's immune response mechanism.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs immunoglobulins produced during fetal development (natural antibodies) as a preliminary immune defense mechanism. These pre-formed antibodies are encapsulated in extracellular vesicles before administration, providing immediate innate immune protection upon delivery, rather than requiring time for the host to develop adaptive immunity responses.

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If fetal stem cells are cultured under conditions mimicking pregnancy to produce extracellular vesicles with immunoglobulins, then natural antibodies are secreted and expressed, but complex culture conditions including temperature change and vibration are required

Engineering Contradiction:
Improveconcentration of immunoglobulinsVSAvoidculture system complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent utilizes physiological temperature fluctuations (mimicking maternal body temperature changes during pregnancy) and mechanical vibration parameters to stimulate fetal stem cells to secrete extracellular vesicles rich in immunoglobulins. By controlling these physical parameters, the system achieves high concentrations of natural antibodies without requiring complex biochemical culture media or growth factors.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The fetal stem cells are induced to self-produce and self-secret e extracellular vesicles containing immunoglobulins under simulated physiological conditions. The cells naturally express and secrete the five types of immunoglobulins (IgM, IgG3, IgA, IgD, IgE) without requiring external addition of these proteins, leveraging the cells' inherent biological capabilities.

Inventive Principle:
Principle #25Self-service

3Adaptability or versatility

If extracellular vesicles containing all five types of immunoglobulins are produced, then comprehensive innate immunity is enhanced, but the production process requires specific culture conditions with temperature change and vibration

Engineering Contradiction:
Improvebreadth of immune coverageVSAvoidsimplicity of production process
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent produces a single type of extracellular vesicle that simultaneously contains all five types of immunoglobulins (IgM, IgG3, IgA, IgD, IgE), providing comprehensive coverage against various pathogens including bacteria, viruses, fungi, and parasites. This multi-functional vesicle formulation eliminates the need for separate production and combination of different antibody therapies.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The culture process employs periodic temperature changes (mimicking circadian rhythm and maternal body temperature variations) and rhythmic vibration to stimulate continuous secretion of extracellular vesicles. This periodic stimulation maintains high production levels of immunoglobulins throughout the culture period without requiring constant intervention or media changes.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS12150962B2Method for producing extracellular vesicles comprising fetus-derived primal immunoglobulin
Publication Date: 2024.11.26 STEMMEDICARE
  • US12150962B2 patent drawing
  • US12150962B2 patent drawing
  • US12150962B2 patent drawing

AI summary

A fetal stem cell-derived extracellular vesicle has immune tolerance properties. The extracellular vesicle containing a fetal stem cell-derived primal immunoglobulin contains various natural antibodies and complement proteins which can immediately respond to foreign infectious agents such as viruses, bacteria, pathogens, etc., and thus can effectively treat and prevent infectious diseases through an enhanced innate immune system. Methods are disclosed for preparing the fetal stem cell-derived extracellular vesicle.